Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |